ArticleJournal of the American Heart Association2024

Differing Efficacy of Dapagliflozin Versus Empagliflozin on the Risk of Incident Atrial Fibrillation in Patients With Type 2 Diabetes: A Real-World Observation Using a Nationwide, Population-Based Cohort.

Jaehyun Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.